Jefferies Financial Group Inc. Seagen Inc. Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $967,125 - $1.09 Million	5,050 Added 11.74%	48,050 $10.2 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $1.92 Million - $2.11 Million	-10,250 Reduced 19.25%	43,000 $8.28 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $5.57 Million - $8.86 Million	43,632 Added 453.65%	53,250 $10.8 Million
Q4 2022 Sep 21, 2023	SELL	$117.37 - $139.17 $4.9 Million - $5.81 Million	-41,750 Reduced 97.09%	1,250 $160,000
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $1.13 Million - $1.34 Million	9,618 New	9,618 $1.24 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.